Ichor Holdings, Ltd. designs, engineers, and manufactures critical fluid delivery subsystems and precision-machined components primarily for semiconductor capital equipment. The company's gas and chemical delivery subsystems are essential elements of process tools used in etch, deposition, chemical-mechanical planarization, electroplating, and cleaning steps during semiconductor fabrication. Headquartered in Fremont, California, with significant operations in Singapore, Ichor serves leading original equipment manufacturers (OEMs) in the global semiconductor equipment market. The company also supplies adjacent industries including defense, aerospace, and medical technology. With approximately 1,891 employees and a market capitalization exceeding $3.4 billion, Ichor is a mid-cap pure-play on semiconductor manufacturing expansion — a theme that has captured intense investor attention amid the artificial intelligence boom. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Ichor Holdings delivered an extraordinary strong performance over the 30-day period from May 19 to June 18, 2026, with the stock climbing from an adjusted close of $64.58 to $98.61. During this window, ICHR set multiple new 52-week highs, culminating in an intraday peak of $99.60 on June 18. The quarterly performance is even more striking: from a close of $51.12 on March 19, 2026, the stock has appreciated roughly 93%, effectively doubling in roughly three months. This sustained upward trajectory has been marked by elevated trading volumes — the 10-day average volume exceeding 1.1 million shares — signaling robust institutional participation. The stock's year-to-date gain stands at approximately 374%, making ICHR one of the standout performers in the semiconductor equipment space. From what I see, the volume profile supports the idea that this move has real institutional backing.
The primary catalyst behind ICHR's 30-day surge was the company's Q1 2026 earnings report released in early May. Ichor posted revenue of $256.07 million, surpassing the $251.32 million consensus estimate, and delivered earnings per share of $0.15 versus the $0.13 analysts expected. The company also provided Q2 profitability guidance that signaled a meaningful inflection point after several quarters of margin compression. This earnings beat ignited a sharp re-rating, with the stock jumping over 8% on May 4 alone.
Beyond earnings, the broader semiconductor equipment sector experienced a powerful rally driven by accelerating AI-related capital expenditure. Memory manufacturers, particularly those supplying high-bandwidth memory (HBM) for AI accelerators, have ramped up orders for fabrication tools — directly benefiting Ichor's fluid delivery subsystem business. On June 11, ICHR surged approximately 16.5% in a single session, reportedly tied to AI-driven HBM and memory demand headlines. I checked the pattern activity around that date using Tickeron’s AI Real Time Patterns for additional context.
Analyst activity further amplified the move. B. Riley raised its price target to $125 from $90, while Stifel, Needham, and Oppenheimer had all issued upgrades in preceding months. The company also announced a $200 million at-the-market equity offering program in mid-May, which, while dilutive in nature, was interpreted by the market as a sign of management confidence and a tool to fund growth initiatives. Institutional ownership stands at over 93%, underscoring deep professional investor conviction in the ICHR story.
Ichor's quarterly performance reflects a confluence of company-specific execution and macro-sector tailwinds. The turnaround narrative began gaining traction after the company's Q4 2025 results in February, which showed revenue of $189 million — up 22% sequentially — and positive operational cash flow. That report triggered a wave of analyst upgrades: B. Riley lifted its rating from Neutral to Buy, and Stifel followed with a Hold-to-Buy upgrade in March.
The broader semiconductor equipment industry has benefited from a structural upcycle tied to AI infrastructure investment. The Philadelphia Semiconductor Index (SOX) crossed the 10,000 threshold during this period, and equipment suppliers like UCTT, ENTG, and ONTO have all posted substantial gains. Ichor's specialized niche — gas and chemical delivery systems that precisely control the reactive environments inside wafer fabrication tools — has made it a direct beneficiary as chipmakers expand capacity for leading-edge nodes. The appointment of Phil Barros as CEO and a clear strategic focus on operational efficiency have also contributed to improving investor sentiment over the quarter.
In a market environment where rapid price moves can create both opportunity and risk, I find it helpful to review data-driven tools for additional perspective. Tickeron's Trending AI Robots page showcases a curated selection of top-performing AI-powered trading bots from a universe of hundreds that trade thousands of tickers. These bots employ diverse strategies — ranging from short-term momentum plays to longer-duration trend-following approaches — and are ranked by verified performance metrics. Only the most relevant and consistently performing bots appear in this section, giving traders a filtered view of algorithmic strategies actively navigating current market conditions. I’ve referenced this page a few times recently when looking at names in the semiconductor space, and it offers a useful way to see how automated systems are positioned around stocks like ICHR.
Looking ahead, several factors will shape ICHR's trajectory. The company's next earnings report, estimated for early August 2026, will be pivotal — analysts expect Q2 revenue around $300 million and EPS of approximately $0.31. Any deviation from these figures, particularly in gross margin performance, could trigger significant price action. Macroeconomic risks, including potential shifts in Federal Reserve policy and trade restrictions on semiconductor equipment exports, remain relevant. The pace of AI infrastructure spending by major chipmakers and memory manufacturers will directly influence order flow for Ichor's subsystems. Competitive dynamics with peers such as Ultra Clean Holdings also warrant monitoring. Finally, the company's use of its newly established at-the-market offering program and any M&A activity could alter the capital structure and growth trajectory. While the momentum is powerful, the stock's elevated valuation — trading at a forward P/E above 55 — means execution must remain near-flawless to sustain current levels. One thing that stands out is how closely the next few quarters will test whether this re-rating holds.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
ICHR saw its Momentum Indicator move below the 0 level on October 12, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 84 similar instances where the indicator turned negative. In 76 of the 84 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for ICHR turned negative on October 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 39 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 78%.
ICHR moved below its 50-day moving average on October 07, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ICHR crossed bearishly below the 50-day moving average on October 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.
The 50-day moving average for ICHR moved below the 200-day moving average on October 14, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ICHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for ICHR entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator entered the oversold zone -- be on the watch for ICHR's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +13.19% 3-day Advance, the price is estimated to grow further. Considering data from situations where ICHR advanced for three days, in 253 of 328 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
ICHR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 13 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.594) is normal, around the industry mean (6.211). P/E Ratio (-31.487) is within average values for comparable stocks, (81.436). Projected Growth (PEG Ratio) (0.251) is also within normal values, averaging (0.801). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (1.761) is also within normal values, averaging (27.897).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. ICHR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ICHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a holding company whose subsidiary manufactures gas and chemical delivery systems for semiconductor process equipment
Industry ElectronicProductionEquipment